Astraea Therapeutics LLC

Mountain View, CA

UEI
ZNNQAFC5FXH3
CAGE
56HV6
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
320 Logue Ave #142, Mountain View, CA 94043, USA
Founded
2009
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Development of nociceptin receptor agonists for alcohol use disorders, period of performance 09/28/15 - 09/27/17; cpff HHSN275201500005C National Institute of Child Health and Human Development (NIH) $999,993
Nociceptin receptor agonists for alcohol use disorders HHSN275201300005C National Institute of Child Health and Human Development (NIH) $297,170

Grant awards

Award Agency Obligated Awarded
First-in-human clinical development of a novel drug candidate with a first-in-class mechanism for smoking cessation and… U01DA054882 National Institute on Drug Abuse (NIH) $14,632,816
Validating the nociceptin receptor for treating craving and withdrawal-associated affect in cocaine addiction… U18DA052559 National Institute on Drug Abuse (NIH) $229,620
Development of next-generation pharmacotherapy for opioid use disorders UH3DA048371 National Institute on Drug Abuse (NIH) $10,330,379
Development of next-generation pharmacotherapy for opioid use disorders UG3DA048371 National Institute on Drug Abuse (NIH) $2,916,188
Development of a novel drug candidate with a first-in-class mechanism for smoking cessation, relapse and abstinence U01DA047791 National Institute on Drug Abuse (NIH) $3,946,553

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Astraea Therapeutics LLC registered in SAM.gov?

Yes. Astraea Therapeutics LLC's SAM.gov registration is active through January 16, 2027.

What is Astraea Therapeutics LLC's CAGE code?

Astraea Therapeutics LLC's CAGE code is 56HV6, and its Unique Entity ID (UEI) is ZNNQAFC5FXH3.

What is Astraea Therapeutics LLC's most recent federal award?

Astraea Therapeutics LLC's most recent federal grant award is First-in-human clinical development of a novel drug candidate with a first-in-class mechanism for smoking cessation and… (U01DA054882), from National Institute on Drug Abuse (NIH), on August 1, 2021.

On GovTribe

See Astraea Therapeutics LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe